Menopause associated with increased prevalence of cardiovascular autonomic neuropathy in women with diabetes: this study

Published Date: 02 Mar 2023

Spain: A recent study showed an increase in subclinical autonomic neuropathy (CAN) in women aged 1...

Read Full News

Latest News

Novo and Hims to Sell Obesity Drugs Together as Feud Ends, Bloomberg News Reports

Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on ⁠Hims & Hers Health platform, bringing an end to a dispute between the ⁠two companies that escalated...

Women at Higher Risk for Smoking Relapse Than Men

Women face biological, hormonal, and psychosocial factors that complicate smoking cessation, prompting experts to call for sex-specific strategies to improve quit success.

How Policy and New Drugs Reshaped Obesity Treatment

The 2013 declaration of obesity as a chronic disease and the 2021 approval of semaglutide are associated with increased use of antiobesity medications, while bariatric surgery rates remain stable.

Self-Insulin Dosing Leads to Control in Gestational Diabetes

In individuals with gestational diabetes, patient-led insulin titration is linked to faster glycemic control and a lower risk for macrosomia than clinician-led approaches.

Chemical Exposure Detected in Semen Linked to Sperm Quality

High-resolution mass spectrometry identifies 42 nonvolatile organic compounds in semen samples from healthy young men.

Some US Medical Schools to Teach Nutrition Under Government Deal

About a fourth of U.S. medical schools will expand their nutrition education offerings this autumn as part of a ⁠deal with the administration of President Donald Trump, said...

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Latest News

Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on ⁠Hims & Hers Health platform, bringing an end to a dispute between the ⁠two companies that escalated...

Women face biological, hormonal, and psychosocial factors that complicate smoking cessation, prompting experts to call for sex-specific strategies to improve quit success.

The 2013 declaration of obesity as a chronic disease and the 2021 approval of semaglutide are associated with increased use of antiobesity medications, while bariatric surgery rates remain stable.

In individuals with gestational diabetes, patient-led insulin titration is linked to faster glycemic control and a lower risk for macrosomia than clinician-led approaches.

High-resolution mass spectrometry identifies 42 nonvolatile organic compounds in semen samples from healthy young men.

About a fourth of U.S. medical schools will expand their nutrition education offerings this autumn as part of a ⁠deal with the administration of President Donald Trump, said...

News All Time

GLP-1 vs DPP-4 Meds: Which Is Better for Diabetes Control?

Sustained GLP-1 receptor agonist therapy is linked to greater improvements in A1c levels than DPP-4 inhibitor therapy in patients with type 2 diabetes, a Danish real-world analysis shows.

Bariatric Surgery Rates Fall as GLP-1s Gain Popularity

The use of GLP 1s increased dramatically from 2018 to 2025 among patients eligible for metabolic and bariatric surgery in the US, whereas surgery rates declined notably.

Lobectomy: Viable Alternative in Medullary Thyroid Carcinoma

Thyroid lobectomy may provide oncologic outcomes similar to those of total thyroidectomy in patients with sporadic medullary thyroid carcinoma, per a meta-analysis of 1371 patients from nine studies.

‘Generation GLP-1’ Drives GLP-1-Friendly Food Marketing

Experts warn the label is ‘more marketing than medical’; urge following evidence on nutritional recommendations for GLP-1 therapy.

Vitamin D Deficiency Linked to Dry Eye Disease

Adults with a deficiency of vitamin D are at increased risk for developing dry eye disease than those without low levels of the nutrient, a study finds.

US FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded Weight‑loss Drugs

The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading ⁠claims about compounded versions of popular GLP-1...

US FDA Warns Novo Again About Misleading Drug Advertising

The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster diabetes drug, ⁠Ozempic, saying the commercial makes false and...

Scenarios Show How to Plan for Osteoporosis Drug Sequences

Gina Woods, MD, shares three case scenarios of sequential treatment decision-making for long-term therapy and discusses research that can inform clinical decisions.

HRT Patches Superior to Oral Meds for FHA-Related Bone Loss

With the risk for bone fracture high in patients with amenorrhea caused by anorexia or excessive exercise, studies show transdermal HRT provides more favorable bone benefits than oral HRT.

Does HRT Lower Osteoporosis Risk?

New research suggests early initiation of hormone replacement therapy could protect bone health.

Treat Aging, Not Diseases, to Extend Healthspan

Targeting aging rather than individual diseases could add more than a decade of healthy life, researchers say, citing centenarian studies and drug repurposing efforts.

Aardvark Pauses Late-stage Trial Testing Rare Disease Treatment

Aardvark Therapeutics is voluntarily pausing its late-stage trial testing its experimental treatment for a ⁠type of rare genetic disease after it found heart-related side...

FDA Okays New Indications for Once-Weekly Growth Hormone

Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

Daily Oral Option for Acromegaly Wins EU Backing

Palsonify, a once-daily oral SST2 agonist, offers a noninvasive alternative to monthly depot injections, long considered the standard medical therapy for acromegaly.

Widely Used Procedure Questionable for Pancreatitis Patients

Pivotal study shows no clear benefit for the common endoscopic procedure in this patient group. Experts say the new data could help avoid unnecessary cost and risk.

Can OTC Remedies Help With GLP-1 Adherence?

GI side effects from GLP-1s may cause patients to drop the medications or turn to OTC remedies. Gastroenterologists don’t rule them out but also cite lack of evidence.

Recommended News For You

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

Global inequalities found in cancer research funding

Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT

Losing a reward can affect your motivation and performance.

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

Certain surgical gestures during prostate removal linked to better sexual function recovery

Many patients learn they could have cancer in the emergency department

Recommended Articles For You

AI-Powered Case Studies in Oncology: Elevating Clinical Influence Through Real-World Data 

Uncovering the Reality of Colon Cancer: A Look at Real Images 

Unlocking the Immune Arsenal: A Revolution in Cancer Treatment 

Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

2.

Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.

3.

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

4.

A large study found that monolayers were superior in detecting cancer.

5.

Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.

1.

Does Lactate Signal Anemia? Exploring the Complexities of Hyperlactatemia and Red Blood Cell Health

2.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

3.

New Anticoagulants: Balancing Efficacy and Safety in Patients with Atrial Fibrillation

4.

Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself

5.

Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot